Phase 3 Lung Cancer Trial, Recruiting

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

• Adults aged 18 or older, of any gender
• People who have a specific immune system marker in their blood called HLA-A2, confirmed by a central laboratory before the trial begins
• People who have been diagnosed with a type of lung cancer called non-small cell lung cancer (NSCLC) that has spread to other parts of the body, is not suitable for surgery or radiation as a primary treatment, and does not have certain gene changes (EGFR, ALK, or ROS1) that would make them eligible for targeted therapy — though some exceptions may apply depending on age, smoking history, or local availability of targeted treatments (confirm with trial site)
• People whose lung cancer has stopped responding to a type of cancer treatment known as immune checkpoint inhibitor (ICI) therapy after initially responding or stabilising

Who may not be able to join:

• The official criteria note that additional inclusion and exclusion criteria apply under the full trial protocol — the trial site would need to review these with anyone being considered for participation (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.